(2S)-5-[6-[6-[[(4S)-4-carboxy-4-[[4-[(2-imino-4-oxo-4aH-pteridin-6-yl)methylamino]benzoyl]amino]butanoyl]amino]hexyldisulfanyl]hexylamino]-2-[[4-[(2-imino-4-oxo-4aH-pteridin-6-yl)methylamino]benzoyl]amino]-5-oxopentanoic acid

InChIKey	`NLMVCNVFCPWLNL-XLVUVUJJSA-N`
Compound Name	(2S)-5-[6-[6-[[(4S)-4-carboxy-4-[[4-[(2-imino-4-oxo-4aH-pteridin-6-yl)methylamino]benzoyl]amino]butanoyl]amino]hexyldisulfanyl]hexylamino]-2-[[4-[(2-imino-4-oxo-4aH-pteridin-6-yl)methylamino]benzoyl]amino]-5-oxopentanoic acid
Canonical SMILES	`NC1=NC(=O)C2N=C(CNc3ccc(C(=O)N[C@@H](CCC(=O)NCCCCCCSSCCCCCCNC(=O)CC[C@H](NC(=O)c4ccc(NCC5=NC6C(=O)N=C(N)N=C6N=C5)cc4)C(=O)O)C(=O)O)cc3)C=NC2=N1`
Clinical Status	Clinical Multi-Target
Targets (Human+Pathogen)	4
Pfam Stratification	Cross-Family
Avg pChEMBL	N/A
Source	TTD_MultiTarget

2D Structure

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P56524	HDAC4	Homo sapiens	Human	PF12203 PF00850	Clinical	TTD_MultiTarget	TTD_MultiTarget
Q02161	RHD	Homo sapiens	Human	PF00909	Clinical	TTD_MultiTarget	TTD_MultiTarget
Q13547	HDAC1	Homo sapiens	Human	PF00850	Clinical	TTD_MultiTarget	TTD_MultiTarget
Q92769	HDAC2	Homo sapiens	Human	PF00850	Clinical	TTD_MultiTarget	TTD_MultiTarget